EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-SA 4.0

Cost-effectiveness thresholds in policy and practice: do HTA guidelines align with estimates of health opportunity cost?

Peter Murphy iD, Susan Griffin, Simon Walker, Laura Vallejo-Torres iD, Oscar Espinosa iD, Mac Ardy J Gloria, Jessica Ochalek iD

Health Economics, Policy and Law · 19.02.2026 · 1-29

DOI: 10.1017/s1744133126100395 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Health Economics, Policy and Law, online erschienen am 19.02.2026. Verfasst von Peter Murphy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Health Economics, https://ror.org/04m01e293University of York, UK. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Health technology assessment (HTA) processes provide evidence to inform the supply of healthcare, often comparing results from economic evaluation to a policy threshold to judge cost-effectiveness. However, recommended policy thresholds may not always align with empirical estimates of the opportunity costs of health care expenditure, captured by marginal productivity of healthcare expenditure (‘ k ’). Such estimates are needed to inform the net health impact of funding decisions. We map policy thresholds in HTA guidelines against published estimates of k . We extract information from HTA guidelines identified in a previous literature review, including recommended perspective, relevant costs and outcomes, and justification for the threshold. Studies estimating k were obtained from a separate review. Of the 47 included HTA guidelines, 20 state an explicit policy threshold and 12 justify their choice. Estimates of k were available for 13 countries. Among the eight countries with explicit policy thresholds and k estimates, three matched. The recommended perspective influences whether k alone is sufficient or appropriate to inform cost-effectiveness judgements. It is important that guideline setters are aware of empirical estimates of k ; and that economic evaluations consider k to reflect health opportunity costs even where the policy threshold is justified on other grounds.

Schlagwörter

Stichwörter der Autor:innen

cost-effectiveness thresholdhealth technology assessmentmarginal productivityopportunity cost

Autor:innen und Institutionen

  • Centre for Health Economics, https://ror.org/04m01e293University of York, UK.
  • Universidad de Las Palmas de Gran Canaria, Spain.
  • Economic Models and Quantitative Methods Research Group (IMEMC), Centro de Investigaciones para el Desarrollo, Universidad Nacional de Colombia, Colombia.
  • College of Pharmacy, University of the Philippines Manila, Philippines.

ORCID-Profile: Peter Murphy, Laura Vallejo-Torres, Oscar Espinosa, Jessica Ochalek

Zitieren

APA

Murphy, P., Griffin, S., Walker, S., Vallejo-Torres, L., Espinosa, O., Gloria, M. A. J., & Ochalek, J. (2026). Cost-effectiveness thresholds in policy and practice: do HTA guidelines align with estimates of health opportunity cost?. Health Economics, Policy and Law, 1-29. https://doi.org/10.1017/s1744133126100395

Vancouver

Murphy P, Griffin S, Walker S, Vallejo-Torres L, Espinosa O, Gloria MAJ, et al. Cost-effectiveness thresholds in policy and practice: do HTA guidelines align with estimates of health opportunity cost?. Health Economics, Policy and Law. 2026:1-29. doi:10.1017/s1744133126100395

BibTeX
@article{Murphy2026,
  author = {Murphy, Peter and Griffin, Susan and Walker, Simon and Vallejo-Torres, Laura and Espinosa, Oscar and Gloria, Mac Ardy J and Ochalek, Jessica},
  title = {Cost-effectiveness thresholds in policy and practice: do HTA guidelines align with estimates of health opportunity cost?},
  journal = {Health Economics, Policy and Law},
  year = {2026},
  pages = {1--29},
  doi = {10.1017/s1744133126100395}
}
Kostenlos starten →